J Korean Diabetes.  2012 Jun;13(2):85-90. 10.4093/jkd.2012.13.2.85.

Treatment of Alcohol Use Disorder

• Lee KS

• KMID: 2059865
• DOI: http://doi.org/10.4093/jkd.2012.13.2.85

Abstract

Prevention through screening and early intervention in the primary care setting are the best treatment strategies for alcohol use disorder. Alcohol use disorder is characterized by compulsive alcohol use potentially resulting in death. Recognizing alcohol use disorder as a chronic relapsing brain disorder is the starting point for treatment. Binge drinking and prolonged use of alcohol can not only result in changes to one's mood state, cognitive functions, and behavior, but also has damaging effects on the brain and other organs. In addition, prolonged alchol use can result in mental illness, physical disease, or social, financial, or legal problems. Like other chronic diseases such as diabetes or hypertension, alcohol use disorder has no cure, and is characterized by relapses requiring longitudinal long-term management strategies, of which treatment adherence and medication compliance are important components. Treatment for alcohol use disorder will be more effective when it combines biological, psychological, and social context approaches.

Keyword

Alcohol; Diabetes mellitus; Abuse; Dependence; Intervention; Treatment

MeSH Terms

Binge Drinking
Brain
Brain Diseases
Chronic Disease
Diabetes Mellitus
Early Intervention (Education)
Hypertension
Mass Screening
Medication Adherence
Primary Health Care
Recurrence

Reference

1. Leshner AI. Addiction is a brain disease, and it matters. Science. 1997. 278:45–47.

2. Yang JH, Lee KS, Shin SE, Lee MJ, Sung KH. Alcohol dependence: the chemical brain injury. J Korean Acad Addict Psychiatry. 2008. 12:15–23.

3. Lee KS, Shin JH. The relationship between insight and cognitive functions in alcoholics. J Korean Acad Addict Psychiatry. 2009. 13:12–20.

4. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000. 284:1689–1695.

5. Guideline development group. Addiction treatment guidelines series I. Alcohol use disorder. 2011. Seoul: Korean Academy of Addiction Psychiatry;56–58.

6. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for use in primary care. 2001. 2nd ed. Geneva: World Health Organization.

7. Edwards SH, Humeniuk R, Ali R, Monteiro M, Poznyak V. Brief intervention for substance use: a manual for use in primary care. 2003. Geneva: World Health Organization.

8. Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002. 97:279–292.

9. Ambrogne JA. Reduced-risk drinking as a treatment goal: what clinicians need to know. J Subst Abuse Treat. 2002. 22:45–53.

10. Hodgins DC, Leigh G, Milne R, Gerrish R. Drinking goal selection in behavioral self-management treatment of chronic alcoholics. Addict Behav. 1997. 22:247–255.

11. Crews FT, Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol. 2009. 44:115–127.

12. Sellman D. The 10 most important things known about addiction. Addiction. 2010. 105:6–13.

13. Roozen HG, de Waart R, van der Windt DA, van den Brink W, de Jong CA, Kerkhof AJ. A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. Eur Neuropsychopharmacol. 2006. 16:311–323.

14. Mann K, Kiefer F, Spanagel R, Littleton J. Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res. 2008. 32:1105–1110.